Skip to main content

editorial

. 1988 Jun;57(6):527–528. doi: 10.1038/bjc.1988.122

Adjuvant tamoxifen for early breast cancer.

PMCID: PMC2246473 PMID: 3044428

527

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Brincker H., Rose C., Rank F., Mouridsen H. T., Jakobsen A., Dombernowsky P., Panduro J., Andersen K. W. Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer. J Clin Oncol. 1987 Nov;5(11):1771–1778. doi: 10.1200/JCO.1987.5.11.1771. [DOI] [PubMed] [Google Scholar]
Padmanabhan N., Howell A., Rubens R. D. Mechanism of action of adjuvant chemotherapy in early breast cancer. Lancet. 1986 Aug 23;2(8504):411–414. doi: 10.1016/s0140-6736(86)92131-8. [DOI] [PubMed] [Google Scholar]
Sainsbury J. R., Farndon J. R., Needham G. K., Malcolm A. J., Harris A. L. Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet. 1987 Jun 20;1(8547):1398–1402. doi: 10.1016/s0140-6736(87)90593-9. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES